You are here:Home-Chemical Inhibitors & Agonists-Cell Cycle/DNA Damage-Topoisomerase-XR-5000
XR-5000

Chemical Structure : XR-5000

CAS No.: 89459-25-6

XR-5000 (Acridine Carboxamide;DACA;NSC 601316;SN-22995)

Catalog No.: PC-61874Not For Human Use, Lab Use Only.

XR-5000 (Acridine Carboxamide;DACA;NSC 601316;SN-22995) is an inhibitor of topoisomerase I and II for treatment of various types of cancers.

Packing Price Stock Quantity
25 mg Get quote
50 mg Get quote
100 mg Get quote
250 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

    Biological Activity

    XR-5000 (Acridine Carboxamide;DACA;NSC 601316;SN-22995) is an inhibitor of topoisomerase I and II for treatment of various types of cancers.

    Physicochemical Properties

    M.Wt 293.363
    Formula C8H19N3O
    Appearance Solid
    CAS No.
    Storage
    Solide Powder
    -20 °C 12 Months; 4°C 6 Months
    In Solvent
    -80 °C 6 Months; -20°C 6 Months
    Shipping
    Solubility

    10 mM in DMSO

    Chemical Name/SMILES

    N-(2-(Dimethylamino)ethyl)-4-acridinecarboxamide

    References

    1. Twelves CJ, et al. Br J Cancer. 1999 Aug;80(11):1786-91.

    2. Neale MH, et al. Anticancer Drugs. 2000 Jul;11(6):471-8.

    3. Dittrich C, et al. Eur J Cancer. 2003 Feb;39(3):330-4.

    4. Dittrich C, et al. Invest New Drugs. 2003 Aug;21(3):347-52.

    Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    Contact Us sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    Get Quote

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • Additional Information: